These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3180616)

  • 61. Power Doppler sonography in the diagnosis of Graves' disease.
    Arslan H; Unal O; Algün E; Harman M; Sakarya ME
    Eur J Ultrasound; 2000 May; 11(2):117-22. PubMed ID: 10781659
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Thyroid blood flow and uptake of technetium-99m pertechnetate in Graves' disease.
    Sekulić V; Rajić M; Vlajković M; Ilić S; Bogićević M; Antić S; Dimić D
    Hell J Nucl Med; 2006; 9(3):173-6. PubMed ID: 17160158
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ocular myasthenia gravis and Graves disease in a 10-year-old child.
    Koves IH; Cameron FJ; Kornberg AJ
    J Child Neurol; 2009 May; 24(5):615-7. PubMed ID: 19406759
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Graves' disease associated with myasthenia gravis: report of one case.
    Chu HY; Shu SG; Mak SC; Chi CS
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1992; 33(6):457-61. PubMed ID: 1306932
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Childhood Graves disease masquerading as myasthenia gravis.
    Perlman SJ; Zaidman CM
    J Child Neurol; 2013 Oct; 28(10):1309-11. PubMed ID: 22952313
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hypercalcemia due to Graves' disease in a patient with thyroid hemiagenesis.
    Kebapçilar L; Akinci B; Demir T; Bayraktar F; Yeşil S
    Kulak Burun Bogaz Ihtis Derg; 2009; 19(3):159-62. PubMed ID: 19857196
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Grey scale thyroid ultrasonography in the evaluation of patients with Graves' disease.
    Vitti P
    Eur J Endocrinol; 2000 Jan; 142(1):22-4. PubMed ID: 10633216
    [No Abstract]   [Full Text] [Related]  

  • 68. Comparison of methods for thyroid volume estimation in patients with Graves' disease.
    van Isselt JW; de Klerk JM; van Rijk PP; van Gils AP; Polman LJ; Kamphuis C; Meijer R; Beekman FJ
    Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):525-31. PubMed ID: 12541136
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Thymic hyperplasia in patients with Graves' disease. Identification of thyrotropin receptors in human thymus.
    Murakami M; Hosoi Y; Negishi T; Kamiya Y; Miyashita K; Yamada M; Iriuchijima T; Yokoo H; Yoshida I; Tsushima Y; Mori M
    J Clin Invest; 1996 Nov; 98(10):2228-34. PubMed ID: 8941638
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Thyroid hypoechogenic pattern at ultrasonography as a tool for predicting recurrence of hyperthyroidism after medical treatment in patients with Graves' disease.
    Vitti P; Rago T; Mancusi F; Pallini S; Tonacchera M; Santini F; Chiovato L; Marcocci C; Pinchera A
    Acta Endocrinol (Copenh); 1992 Feb; 126(2):128-31. PubMed ID: 1543017
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Computed tomography of thymic abnormalities.
    Schnyder P; Candardjis G
    Eur J Radiol; 1987 May; 7(2):107-13. PubMed ID: 3595619
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The Sonographic Features of the Thyroid Gland After Treatment with Radioiodine Therapy in Patients with Graves' Disease.
    English C; Casey R; Bell M; Bergin D; Murphy J
    Ultrasound Med Biol; 2016 Jan; 42(1):60-7. PubMed ID: 26603660
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prediction of relapse after antithyroid drug therapy of Graves' disease: value of color Doppler sonography.
    Saleh A; Cohnen M; Fürst G; Mödder U; Feldkamp J
    Exp Clin Endocrinol Diabetes; 2004 Oct; 112(9):510-3. PubMed ID: 15505758
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Combined true thymic hyperplasia and lymphoid hyperplasia in Graves' disease.
    Judd R; Bueso-Ramos C
    Pediatr Pathol; 1990; 10(5):829-36. PubMed ID: 2235767
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Image in endocrinology: thymic hyperplasia in a patient with Graves' disease.
    Kirkeby KM; Pont A
    J Clin Endocrinol Metab; 2006 Jan; 91(1):1. PubMed ID: 16401829
    [No Abstract]   [Full Text] [Related]  

  • 76. Thyroid vascularization by color doppler ultrasonography in Graves' disease. Changes related to different phases and to the long-term outcome of the disease.
    Baldini M; Castagnone D; Rivolta R; Meroni L; Pappalettera M; Cantalamessa L
    Thyroid; 1997 Dec; 7(6):823-8. PubMed ID: 9459623
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Appearance of Graves' disease after percutaneous ethanol injection for the treatment of hyperfunctioning thyroid adenoma.
    Monzani F; Del Guerra P; Caraccio N; Casolaro A; Lippolis PV; Goletti O
    J Endocrinol Invest; 1997 May; 20(5):294-8. PubMed ID: 9258811
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Incidental finding of thyroid uptake of tc-99m tetrofosmin on a myocardial perfusion scan.
    Kannan S; Ravi Kumar AS; Griffiths M
    Clin Nucl Med; 2007 Jan; 32(1):73-5. PubMed ID: 17179815
    [No Abstract]   [Full Text] [Related]  

  • 79. Characteristics of two-dimensional and color Doppler ultrasonography in Graves' disease.
    Li J; Zhang J; Bai Y; Cheng Y; Cai S; Sun H
    Chin Med Sci J; 1994 Jun; 9(2):104-7. PubMed ID: 8000055
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
    Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
    J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.